CLINICAL TRIALS PROFILE FOR DDAVP (NEEDS NO REFRIGERATION)

All Clinical Trials for DDAVP (NEEDS NO REFRIGERATION)

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00097123 ↗	RCT of Misoprostol for Postpartum Hemorrhage in India	Completed	Bill and Melinda Gates Foundation	N/A	2002-09-01	Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 ↗	RCT of Misoprostol for Postpartum Hemorrhage in India	Completed	Fogarty International Center of the National Institute of Health	N/A	2002-09-01	Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 ↗	RCT of Misoprostol for Postpartum Hemorrhage in India	Completed	Global Network for Women's and Children's Health Research	N/A	2002-09-01	Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 ↗	RCT of Misoprostol for Postpartum Hemorrhage in India	Completed	Jawaharlal Nehru Medical College	N/A	2002-09-01	Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 ↗	RCT of Misoprostol for Postpartum Hemorrhage in India	Completed	John E. Fogarty International Center (FIC)	N/A	2002-09-01	Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 ↗	RCT of Misoprostol for Postpartum Hemorrhage in India	Completed	National Cancer Institute (NCI)	N/A	2002-09-01	Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 ↗	RCT of Misoprostol for Postpartum Hemorrhage in India	Completed	National Center for Complementary and Integrative Health (NCCIH)	N/A	2002-09-01	Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.

Clinical Trial Conditions for DDAVP (NEEDS NO REFRIGERATION)

Condition Name

Condition Name for DDAVP (NEEDS NO REFRIGERATION)
Intervention	Trials
Postpartum Hemorrhage	2
Asthma; Status	1
HIV-1	1
Post-operative Pain for Total Knee Arthroplasty	1

Condition MeSH

Condition MeSH for DDAVP (NEEDS NO REFRIGERATION)
Intervention	Trials
Hemorrhage	4
Postpartum Hemorrhage	3
HIV Infections	2
Wounds and Injuries	2

Clinical Trial Locations for DDAVP (NEEDS NO REFRIGERATION)

Trials by Country

Trials by Country for DDAVP (NEEDS NO REFRIGERATION)
Location	Trials
United States	20
India	4
Brazil	4
Canada	3
South Africa	2

Trials by US State

Trials by US State for DDAVP (NEEDS NO REFRIGERATION)
Location	Trials
Texas	4
Florida	2
North Carolina	1
Georgia	1
Tennessee	1

Clinical Trial Progress for DDAVP (NEEDS NO REFRIGERATION)

Clinical Trial Phase

Clinical Trial Phase for DDAVP (NEEDS NO REFRIGERATION)
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	5
Phase 2/Phase 3	3

Clinical Trial Status

Clinical Trial Status for DDAVP (NEEDS NO REFRIGERATION)
Clinical Trial Phase	Trials
Completed	13
Not yet recruiting	3
Unknown status	3

Clinical Trial Sponsors for DDAVP (NEEDS NO REFRIGERATION)

Sponsor Name

Sponsor Name for DDAVP (NEEDS NO REFRIGERATION)
Sponsor	Trials
Bruyere Research Institute	2
United States Department of Defense	2
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	2

Sponsor Type

Sponsor Type for DDAVP (NEEDS NO REFRIGERATION)
Sponsor	Trials
Other	39
NIH	9
Industry	5